Senior Medical Director, Cancer Immunotherapy Development

1110 Kite Pharma, Inc.; Foster City (CA); Vor Ort; USD 275.000 - 391.000; Vollzeit

Benefits dieser Stelle

Discretionary bonus

Stock-based incentives

Paid time off

Benefits package

Zusammenfassung

Kite Pharma, Inc. is seeking a Senior Medical Director to provide clinical oversight for one or more clinical trials and guide project teams in designing and implementing studies with high quality, efficiency, and regulatory alignment.

The role supports BLA/MAA filings and cross-functional collaboration across R&D, regulatory, and medical affairs. The candidate will lead clinical development strategies, interact with investigators and thought leaders, and may present at conferences while

Qualifikationen

• MD/DO with extensive clinical research or drug development experience.
• Experience in clinical development and trials in neuroscience or related fields.
• Ability to design, monitor and interpret clinical studies at high quality.

Aufgaben

• Provide clinical oversight and medical monitoring to one or more clinical trials
• Lead project teams to design and implement clinical studies
• Write protocols, investigator brochures, clinical study reports and review documents
• Conduct investigator meetings and site initiation visits with investigators
• Implement drug development strategic plans and meet milestones and budgets
• Translate research or nonclinical findings into clinical development opportunities
• Interact with investigators and thought leaders and ensure regulatory compliance

Kenntnisse

Clinical oversight

Ausbildung

MD/DO

Jobbeschreibung

Kite Pharma, Inc. is seeking a Senior Medical Director to provide clinical oversight for one or more clinical trials and guide project teams in designing and implementing studies with high quality, efficiency, and regulatory alignment.

The role supports BLA/MAA filings and cross-functional collaboration across R&D, regulatory, and medical affairs. The candidate will lead clinical development strategies, interact with investigators and thought leaders, and may present at conferences while